IpaB/IpaD fusion protein shigella vaccine (PATH)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIpaB/IpaD fusion protein shigella vaccine (PATH)

Drug Alias Nameshigella vaccine (PATH)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsDysentery, Bacillary

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPath

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPath

Active IndicationsN/A

Inactive IndicationsDysentery, Bacillary

Other Information

ATC CodeN/A